Consensus vs Rayyan (2026)

Consensus

by Consensus

Rayyan

by Rayyan

Pros

• ✓Answers are drawn from the peer-reviewed literature with inline citations, and Citation Grounding shows the exact quote behind every AI citation.
• ✓The Consensus Meter shows how far studies agree on a yes-or-no question, and Deep Search and the Research Agent run multi-step literature research.
• ✓An MCP server and REST API come with paid plans, and Consensus runs as an app inside ChatGPT, Claude and Microsoft 365 Copilot.
• ✓Over 170 university libraries partner with Consensus, and it licenses full text from publishers including Wiley, Sage, Taylor & Francis and AAAS.

Limitations

• ⚠Searches the academic literature rather than the open web, news or company reports, and its default index excludes grey literature.
• ⚠Deep review volume is capped by plan, from 15 a month on Pro to 200 on Deep, and API and MCP use past the included amount costs $0.05 per use.
• ⚠Consensus publishes no third-party security certification, and its privacy policy states it is not subject to the CCPA.
• ⚠The corpus is English-first, and search ranking and summaries are optimized for English queries.

Pros

• ✓Academic-friendly pricing makes systematic review tools accessible where enterprise alternatives cannot. The permanent Free tier (3 reviews, 2 reviewers), Essential at $4.99/seat/month annual, and Advanced at $8.33/seat/month annual sit far below Covidence ($149+/month) and DistillerSR (custom pricing), removing cost as a barrier for graduate students and early-career researchers.
• ✓AI duplicate detection is widely regarded as best-in-category for systematic reviews. It is consistently cited as a primary reason researchers choose Rayyan, cutting time spent on manual deduplication across large citation sets exported from PubMed, Scopus, and Web of Science.
• ✓A 1M+ researcher global base across 20,000+ institutions, plus university library endorsements, provides strong community validation. Research guides at the University of Hawaii, University of Mississippi, and other major institutions recommend Rayyan, and a PMC/NIH peer-reviewed study confirms 97-99% AI screening sensitivity for the Predictor engine.

Limitations

• ⚠Less depth than enterprise systematic review platforms. Rayyan suits academic and individual systematic review but lacks the workflow customization, advanced audit trails, and enterprise-grade reporting that Covidence or DistillerSR provide for high-stakes regulatory and clinical evidence synthesis.
• ⚠Mobile free-tier friction and unexpected collaborator costs: Google Play reviewers report the 100-decision mobile screening limit on the free tier as a meaningful constraint, and invited collaborators on reviews where only the owner holds a paid subscription can face unexpected payment requirements to complete their screening tasks.
• ⚠Specialized for systematic reviews, with no literature discovery or citation analysis. Rayyan covers the evidence synthesis workflow (screening, deduplication, PRISMA) but lacks the deeper literature search of Undermind ($16/mo billed annually), the citation context analysis of Scite.ai ($12/mo billed annually), or the open-web synthesis of Gemini Deep Research.